How to Cope with Nausea and Vomiting During…

Nausea and vomiting are dreaded side effects of chemotherapy. How are these side effects treated? (Source: About.com Lung Cancer)

from #Cancer-Sfakianakis via simeraentaxei on Inoreader http://ift.tt/1nGov5P
via IFTTT Medicine by Alexandros G.Sfakianakis,Anapafseos 5 Agios Nikolaos,Crete 72100,Greece,tel :00302841026182 & 00306932607174

How to Cope with Nausea and Vomiting During…

Increasing the Implementation of Evidence-Based Cancer Survivorship Interventions to Increase Quality and Duration of Life among Cancer Patients

Funding Opportunity Number: CDC-RFA-DP15-150102CONT16 Opportunity Category: ContinuationFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.808Eligible Applicants Others (see text field entitled «Additional Information on Eligibility» for clarification)Agency Name: HHS-CDCClosing Date: Apr 25, 2016Award Ceiling: $0Expected Number of Awards: 50Creation Date: Jan 29, 2016Funding Opportunity Description: Increasing the Implementation of Evidence-Based Cancer Survivorship Interventions to Increase Quality and Duration of Life among Cancer Patients (Source: Grants.gov)

MedWorm Sponsor Message: Directory of the best January Sales in the UK. Find the best Christmas presents too.

from #Cancer-Sfakianakis via simeraentaxei on Inoreader http://ift.tt/1nGov5H
via IFTTT Medicine by Alexandros G.Sfakianakis,Anapafseos 5 Agios Nikolaos,Crete 72100,Greece,tel :00302841026182 & 00306932607174

Increasing the Implementation of Evidence-Based Cancer Survivorship Interventions to Increase Quality and Duration of Life among Cancer Patients

Genetic variants in ABCG1 are associated with survival of nonsmall‐cell lung cancer patients

Cell membrane transporters and metabolic enzymes play a crucial role in the transportation of a wide variety of substrates that maintain homeostasis in biological processes. We explored associations between genetic variants in these genes and survival of nonsmall‐cell lung cancer (NSCLC) patients by reanalyzing two datasets from published genome‐wide association studies (GWASs). In the discovery by using the GWAS dataset of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, we evaluated associations of 1,245 single‐nucleotide polymorphisms (SNPs) in genes of four transporter families and two metabolic enzyme families with survival of 1,185 NSCLC patients. We then performed a replication analysis in the Harvard University Lung Cancer study (LCS) with 984 NSCLC p…

from #Cancer-Sfakianakis via simeraentaxei on Inoreader http://ift.tt/20AsnTI
via IFTTT Medicine by Alexandros G.Sfakianakis,Anapafseos 5 Agios Nikolaos,Crete 72100,Greece,tel :00302841026182 & 00306932607174

Genetic variants in ABCG1 are associated with survival of nonsmall‐cell lung cancer patients

Cancer incidence among alcoholic liver disease patients in Finland: A retrospective registry study during years 1996–2013

from #Cancer-Sfakianakis via simeraentaxei on Inoreader http://ift.tt/20AspLf
via IFTTT Medicine by Alexandros G.Sfakianakis,Anapafseos 5 Agios Nikolaos,Crete 72100,Greece,tel :00302841026182 & 00306932607174

Cancer incidence among alcoholic liver disease patients in Finland: A retrospective registry study during years 1996–2013

A model for predicting individuals’ absolute risk of esophageal adenocarcinoma: Moving toward tailored screen ing and prevention

Esophageal adenocarcinoma (EAC) is characterized by rapidly increasing incidence and poor prognosis, stressing the need for preventive and early detection strategies. We used data from a nationwide population‐based case‐control study, which included 189 incident cases of EAC and 820 age‐ and sex‐matched control participants, from 1995 through 1997 in Sweden. We developed risk prediction models based on unconditional logistic regression. Candidate predictors included established and readily identifiable risk factors for EAC. The performance of model was assessed by the area under receiver operating characteristic curve (AUC) with cross‐validation. The final model could explain 94% of all case patients with EAC (94% population attributable risk) and included terms for gastro‐esop…

from #Cancer-Sfakianakis via simeraentaxei on Inoreader http://ift.tt/20AsnmS
via IFTTT Medicine by Alexandros G.Sfakianakis,Anapafseos 5 Agios Nikolaos,Crete 72100,Greece,tel :00302841026182 & 00306932607174

A model for predicting individuals’ absolute risk of esophageal adenocarcinoma: Moving toward tailored screen ing and prevention

Exploring circulating micro‐RNA in the neoadjuvant treatment of breast cancer

Breast cancer is the most frequently diagnosed malignancy amongst females worldwide. In recent years the management of this disease has transformed considerably, including the administration of chemotherapy in the neoadjuvant setting. Aside from increasing rates of breast conserving surgery and enabling surgery via tumour burden reduction, use of chemotherapy in the neoadjuvant setting allows monitoring of in vivo tumour response to chemotherapeutics. Currently, there is no effective means of identifying chemotherapeutic responders from non‐responders. Whilst some patients achieve complete pathological response (pCR) to chemotherapy, a good prognostic index, a proportion of patients derive little or no benefit, being exposed to the deleterious effects of systemic treatment without any kn…

from #Cancer-Sfakianakis via simeraentaxei on Inoreader http://ift.tt/1PNX6es
via IFTTT Medicine by Alexandros G.Sfakianakis,Anapafseos 5 Agios Nikolaos,Crete 72100,Greece,tel :00302841026182 & 00306932607174

Exploring circulating micro‐RNA in the neoadjuvant treatment of breast cancer

Cancer incidence among Asian American populations in the United States, 2009–2011

Cancer incidence disparities exist among specific Asian American populations. However, the existing reports exclude data from large metropoles like Chicago, Houston and New York. Moreover, incidence rates by subgroup have been underestimated due to the exclusion of Asians with unknown subgroup. Cancer incidence data for 2009 to 2011 for eight states accounting for 68% of the Asian American population were analyzed. Race for cases with unknown subgroup was imputed using stratified proportion models by sex, age, cancer site and geographic regions. Age‐standardized incidence rates were calculated for 17 cancer sites for the six largest Asian subgroups. Our analysis comprised 90,709 Asian and 1,327,727 non‐Hispanic white cancer cases. Asian Americans had significantly lower overall cancer …

from #Cancer-Sfakianakis via simeraentaxei on Inoreader http://ift.tt/20Asn6e
via IFTTT Medicine by Alexandros G.Sfakianakis,Anapafseos 5 Agios Nikolaos,Crete 72100,Greece,tel :00302841026182 & 00306932607174

Cancer incidence among Asian American populations in the United States, 2009–2011